Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC Early Clinical Trials Group.

S Aamdal; I Wolff; S Kaplan; R Paridaens; J Kerger; J Schachter; J Wanders; H R Franklin; J Verweij

doi:10.1016/0959-8049(94)90456-1

Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC Early Clinical Trials Group.

Identifier:nobleid.org/w1/20260515/BCB2EDC0

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BCB2EDC0.svg?ark=w1%2F20260515%2FBCB2EDC0)](https://nobleid.org/work/w1/20260515/BCB2EDC0)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC Early Clinical Trials Group.

Identifier:nobleid.org/w1/20260515/BCB2EDC0

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BCB2EDC0.svg?ark=w1%2F20260515%2FBCB2EDC0)](https://nobleid.org/work/w1/20260515/BCB2EDC0)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work